D. Ollila

发表

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial

A. Giuliano, N. Hansen, K. Hunt, 2017, JAMA.

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

C. Perou, L. Carey, D. Moore, 2007, Clinical Cancer Research.

Implementing a Program of Talimogene laherparepvec

D. Ollila, F. Collichio, Lauren M. B. Burke, 2018, Annals of Surgical Oncology.

Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer.

L. Carey, C. Livasy, A. Ivanova, 2012, The oncologist.

Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer.

A. Giuliano, M. Brennan, D. Ollila, 1998, Archives of surgery.

Lymphatic mapping and sentinel lymphadenectomy: critical review of technique.

D. Ollila, E. L. Rager, E. Rager, 2001, Breast disease.

Critical review of the sentinel node hypothesis.

D. Morton, D. Ollila, 1999, Surgery.

Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

A. Giuliano, R. Turner, S. Masood, 1997, Annals of surgery.

Relative value unit impact of complex skin closures to academic surgical melanoma practices.

J. Yeh, K. Amos, D. Ollila, 2012, American journal of surgery.

Overview of melanoma vaccines: active specific immunotherapy for melanoma patients.

D. Morton, M. Kelley, D. Ollila, 1998, Seminars in surgical oncology.

Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based Genes, Environment, and Melanoma (GEM) Study.

S. Rosso, C. Begg, S. Gruber, 2018, The Journal of investigative dermatology.

Muir-Torre Syndrome

N. Thomas, D. Ollila, A. Lachiewicz, 2007, American journal of clinical dermatology.

Metastatic melanoma cells in the sentinel node cannot be ignored.

J. Yeh, A. Deal, K. Amos, 2009, Journal of the American College of Surgeons.

Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance)

L. Carey, E. Hwang, K. Ballman, 2021, Annals of Surgical Oncology.

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma

M. Gulley, Douglas B. Johnson, R. Alkallas, 2022, BMC cancer.

Tandem BRAF mutations in primary invasive melanomas.

R. Millikan, K. Conway, S. Edmiston, 2004, The Journal of investigative dermatology.

Surgical Options in Management of the Breast and Axilla: Independent Choices?

J. Boughey, D. Ollila, J. Johnson, 2021, Annals of Surgical Oncology.

Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment

D. Ollila, P. Strassle, K. Gallagher, 2020, Annals of Surgical Oncology.

Extracapsular Extension of the Sentinel Lymph Node Metastasis: A Predictor of Nonsentinel Node Tumor Burden

A. Meyer, B. Calvo, Hong-Jin Kim, 2003, Annals of surgery.

Pulmonary resection for metastatic melanoma

B. McCaughan, D. Ollila, J. Sadoff, 2003 .

Population‐based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma

K. Stitzenberg, L. Beskow, N. Thomas, 2006, Journal of surgical oncology.

How Informed Is the Decision About Breast Reconstruction After Mastectomy?: A Prospective, Cross-sectional Study

Karen R. Sepucha, P. Ubel, K. Sepucha, 2016, Annals of surgery.

Pleomorphic Invasive Lobular Carcinoma of the Breast With Extracellular Mucin and HER2 Amplification

B. Calhoun, D. Ollila, S. O'Connor, 2020, Breast cancer : basic and clinical research.

The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases e A multicenter cohort study

James X. Sun, V. Sondak, R. Dummer, 2022, European journal of cancer.

ASO Author Reflections: More Isn’t Always Best—Shaping the Dialogue to Decrease Overtreatment of the Axilla in the Elderly

D. Ollila, R. Louie, 2020, Annals of Surgical Oncology.

Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer.

L. Carey, C. Livasy, A. Ivanova, 2010, The oncologist.

Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study

Amanda K Silva, B. Qaqish, D. Moore, 2017, Plastic and reconstructive surgery.

Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients?

K. Stitzenberg, D. Ollila, P. Strassle, 2020, American journal of surgery.

Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience

A. Ivanova, Carrie Lee, S. Moschos, 2019, Oncology.

Clinical and translational results of CALGB 40601: A neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer.

D. Berry, C. Perou, E. Winer, 2013 .

Breast Surgeon's Survey: No Consensus for Surgical Treatment of Pleomorphic Lobular Carcinoma In Situ

E. Hwang, D. Ollila, V. Malcarne, 2013, The breast journal.

Feasibility of Breast Preserving Therapy with Single Fraction In Situ Radiotherapy Delivered Intraoperatively

Sha X. Chang, J. Lian, C. Livasy, 2007, Annals of Surgical Oncology.

Cosmetic Outcomes for Accelerated Partial Breast Irradiation Prior to Surgical Excision of Early Stage Breast Cancer Using Single Dose Intraoperative Radiotherapy

J. Lian, C. Livasy, D. Moore, 2011 .

In Vivo Intraoperative Radiotherapy: A Novel Approach to Radiotherapy for Early Stage Breast Cancer

J. Tepper, B. Calvo, Hong-Jin Kim, 2007, Annals of Surgical Oncology.

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

D. Morton, S. O’Day, D. Ollila, 2004, Cancer Immunology, Immunotherapy.

Metastasectomy for recurrent stage IV melanoma

D. Morton, D. Ollila, E. Hsueh, 1999, Journal of surgical oncology.

The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer

P. Spanheimer, D. Ollila, P. Strassle, 2020, Annals of Surgical Oncology.

Tumor Mitotic Rate and Association with Recurrence in Sentinel Lymph Node Negative Stage II Melanoma Patients

J. Yeh, A. Deal, K. Stitzenberg, 2017, The American surgeon.

Local Control Following Single-Dose Intraoperative Radiotherapy Prior to Surgical Excision of Early-Stage Breast Cancer

J. Lian, C. Livasy, D. Moore, 2011, Annals of Surgical Oncology.

Postoperative Hypocalcemia after Parathyroidectomy for Renal Hyperparathyroidism in the Era of Cinacalcet

B. Calvo, Hong-Jin Kim, J. Yeh, 2009, The American surgeon.

Blue urticaria: a previously unreported adverse event associated with isosulfan blue.

T. Sadiq, D. Ollila, D. Taber, 2001, Archives of surgery.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma

C. Miller, David B. Darr, N. Sharpless, 2015, Clinical Cancer Research.

Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial

S. Mclaughlin, T. Julian, T. Buchholz, 2012 .

Mastectomy May Be an Inferior Oncologic Approach Compared to Breast Preservation.

G. Gupta, L. Marks, H. Muss, 2019, International journal of radiation oncology, biology, physics.

Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

S. Rosso, C. Begg, S. Gruber, 2017, The Journal of investigative dermatology.

Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression.

Mary K. Bryant, D. Ollila, P. Strassle, 2020, Journal of surgical oncology.

High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.

A. Meyer, L. Carey, B. Calvo, 2004, American journal of surgery.

Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients.

B. Calvo, Hong-Jin Kim, C. Hultman, 2005, American journal of surgery.

Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience

James X. Sun, K. Delman, D. Ollila, 2021, Annals of Surgical Oncology.

Influence of provider and practice characteristics on melanoma care.

K. Stitzenberg, N. Thomas, D. Ollila, 2007, American journal of surgery.

Experienced Radio-Guided Surgery Teams Can Successfully Perform Minimally Invasive Radio-Guided Parathyroidectomy without Intraoperative Parathyroid Hormone Assays

B. Calvo, Hong-Jin Kim, A. Caudle, 2006, The American surgeon.

Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care.

A. Chagpar, E. Levine, D. Ollila, 2022, The Journal of surgical research.

Ultrasound-guided Intralesional Injection of Talimogene laherparepvec (Imlygic) for Advanced Melanoma: Technical Note on a Preliminary Experience

D. Ollila, F. Collichio, Lauren M. B. Burke, 2021, CardioVascular and Interventional Radiology.

Prospective Evaluation of Radar-Localized Reflector-Directed Targeted Axillary Dissection in Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy.

K. McGuire, C. Kuzmiak, D. Ollila, 2022, Journal of the American College of Surgeons.

Talimogene laherparepvec and novel injectable oncolytic viruses in the management of metastatic melanoma

D. Ollila, F. Collichio, Frances G. Jenkins, 2021, Journal of Translational Genetics and Genomics.

Combined modality neoadjuvant treatment for stage III/IV melanoma with PD-1 blockade plus radiation: A case series

L. Dodd, Michail Alevizakos, S. Moschos, 2017 .

Therapeutic axillary lymph node dissection for metastatic melanoma

D. Ollila, W. McCarthy, E. Felger, 2003 .

Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients.

A. Chagpar, E. Levine, D. Ollila, 2021, American journal of surgery.

PAX3 Is Extensively Expressed in Benign and Malignant Tissues of the Melanocytic Lineage in Humans

C. Begg, K. Conway, S. Edmiston, 2010 .

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

S. Mclaughlin, H. Kuerer, K. Hunt, 2013, JAMA.

Ductal Carcinoma In Situ Simultaneously Involving the Breast and Epithelial Inclusions in an Ipsilateral Axillary Lymph Node

B. Calhoun, D. Ollila, S. O'Connor, 2018, International journal of surgical pathology.

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma

David L. Marron, D. Hayes, K. Hoadley, 2019, Front. Oncol..

Historical review of melanoma treatment and outcomes.

S. Moschos, D. Ollila, F. Collichio, 2013, Clinics in dermatology.

Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

S. Rosso, C. Begg, S. Gruber, 2014, JAMA dermatology.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

C. J. Thompson, C. Amos, I. Gorlov, 2022, medRxiv.

Age and Breslow depth are associated with a positive sentinel lymph node in patients with cutaneous melanocytic tumors of uncertain malignant potential.

J. Woosley, J. Yeh, A. Deal, 2010, Journal of the American College of Surgeons.

Characterization of the CpG island hypermethylated phenotype (CIMP) subclass in primary melanomas.

J. Parker, K. Conway, S. Edmiston, 2021, The Journal of investigative dermatology.

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features

K. Conway, S. Edmiston, M. Berwick, 2014, Pigment cell & melanoma research.

Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study

S. Rosso, C. Begg, S. Gruber, 2021, Current oncology.

Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study

S. Rosso, C. Begg, S. Gruber, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

S. Rosso, C. Begg, S. Gruber, 2015, JAMA oncology.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

S. Rosso, C. Begg, S. Gruber, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.

D. Morton, S. O’Day, X. Ye, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma

S. Rosso, C. Begg, S. Gruber, 2017, JAMA dermatology.

Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma

D. Morton, R. Essner, D. Ollila, 1999, CA: a cancer journal for clinicians.

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

D. Berry, C. Perou, E. Winer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma

Derek Y. Chiang, J. Parker, N. Sharpless, 2014, Pigment cell & melanoma research.

Methylation of nonessential genes in cutaneous melanoma – Rule Out hypothesis

C. Begg, I. Gorlov, R. Shen, 2023, Melanoma research.

LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

C. Perou, C. Miller, Kwok-Kin Wong, 2012, Cancer cell.

Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma

R. Millikan, C. Begg, A. Hummer, 2007, Cancer Epidemiology Biomarkers & Prevention.

Vascular channels formed by subpopulations of PECAM1+ melanoma cells

P. Dayton, J. M. Shields, R. Brekken, 2014, Nature Communications.

Appendix cancer mimicking ovarian cancer

P. Gehrig, J. Boggess, D. Ollila, 2002, International Journal of Gynecologic Cancer.

Indications for Lymphatic Mapping and Sentinel Lymphadenectomy in Patients with Thin Melanoma (Breslow Thickness ≤1.0 mm)

T. Hensing, K. Stitzenberg, N. Thomas, 2004, Annals of Surgical Oncology.

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

M. Wilkerson, J. Parker, K. Conway, 2019, The Journal of investigative dermatology.

CORRESPONDENCE AND BRIEF REPORTS

P. Gehrig, J. Boggess, D. Ollila, 2002 .

Systematic Review: Surgery for Patients with Metastatic Melanoma during Active Treatment with Ipilimumab

K. Stitzenberg, D. Ollila, F. Collichio, 2014, The American surgeon.

Optimum excision margins for melanoma

D. Ollila, J. Thompson, 2011, The Lancet.

Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition

T. Barker, M. Troester, Wei Li, 2018, British Journal of Cancer.

Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis

J. Parker, K. Conway, S. Edmiston, 2019, The American Journal of dermatopathology.

Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.

D. Ollila, Erika L Rager, Edward P Bridgeford, 2005, American family physician.

Sentinel Lymph Node Biopsy During Pregnancy: Initial Clinical Experience

E. Levine, D. Ollila, R. Cuenca, 2006, Annals of Surgical Oncology.

ASO Author Reflections: Accurately Predicting Nodal pCR Holds the Key to Axillary Surgery De-escalation Strategies

M. Golshan, D. Ollila, A. Weiss, 2021, Annals of Surgical Oncology.

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).

D. Berry, E. Winer, C. Hudis, 2017, Journal of the American College of Surgeons.

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).

D. Berry, E. Winer, C. Hudis, 2015, Annals of surgery.

Diagnosis and management of bile leaks following laparoscopic cholecystectomy.

J. Peters, E. Ellison, D. Ollila, 1994, Surgical laparoscopy & endoscopy.

Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trial.

L. Carey, D. Ollila, C. Sartor, 2010, International journal of radiation oncology, biology, physics.

Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays.

B. Calvo, Hong-Jin Kim, A. Caudle, 2006, American journal of surgery.

Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.

K. Amos, K. Stitzenberg, D. Ollila, 2014, American journal of surgery.

Decision making about surgery for early-stage breast cancer.

Karen R. Sepucha, K. Sepucha, Yuchiao Chang, 2012, Journal of the American College of Surgeons.

Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922)

J. Serody, A. Ivanova, E. Dees, 2021, Melanoma research.

Long-Term Outcome of Neoadjuvant Therapy for Locally Advanced Breast Carcinoma: Effective Clinical Downstaging Allows Breast Preservation and Predicts Outstanding Local Control and Survival

L. Carey, B. Calvo, J. Rosenman, 2002, Annals of surgery.

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

S. Rosso, C. Begg, S. Gruber, 2018, The Journal of investigative dermatology.

Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

S. Rosso, C. Begg, S. Gruber, 2016, Journal of the National Cancer Institute.

Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma

S. Rosso, C. Begg, S. Gruber, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.

C. Begg, K. Conway, S. Edmiston, 2010, The Journal of investigative dermatology.

Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?

P. Spanheimer, D. Ollila, K. Gallagher, 2021, The American surgeon.

Size of Residual Lymph Node Metastasis After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Is Prognostic

L. Carey, C. Livasy, B. Calvo, 2006, Annals of Surgical Oncology.

Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).

S. Mclaughlin, R. Jagsi, K. Hunt, 2016, International journal of radiation oncology, biology, physics.

Impact of neoadjuvant therapy on breast conservation rates in triple-negative and HER2-positive breast cancer: Combined results of CALGB 40603 and 40601 (Alliance).

D. Berry, E. Winer, C. Hudis, 2015 .

Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomy

A. Deal, K. Stitzenberg, D. Ollila, 2015, Journal of surgical oncology.

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

D. Berry, E. Winer, C. Hudis, 2016, Breast Cancer Research and Treatment.

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases

J. Kirkwood, B. Vincent, Carrie Lee, 2021, Frontiers in Oncology.

Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).

L. Esserman, N. Hylton, C. Hudis, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical resection for melanoma metastatic to the gastrointestinal tract.

D. Morton, L. Wanek, R. Essner, 1996, Archives of surgery.

Surgery for Stage IV Metastatic Melanoma

D. Ollila, E. Hsueh, S. Laks, 2018 .

Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte‐macrophage colony‐stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma

M. Ross, K. Harrington, J. Nemunaitis, 2016, Head & neck.

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)

James X. Sun, Lesly A. Dossett, V. Sondak, 2021, Cancer.

Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma

Sin-Ho Jung, D. Tyler, M. Selim, 2020, Annals of Surgical Oncology.

Time may Heal All Wounds, but While It Does, Melanoma Marches on

D. Ollila, M. Meyers, 2019, Annals of Surgical Oncology.

Malignant Melanoma Arising From a Giant Congenital Melanocytic Nevus in a 3-Year Old: Review of Diagnosis and Management

P. Googe, D. Ollila, J. Blatt, 2020, The Journal of craniofacial surgery.

American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.

L. Carey, E. Dees, L. Sawyer, 2005, Journal of the National Cancer Institute.

Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma

M. Gulley, N. Thomas, D. Ollila, 2014, Journal of cutaneous pathology.

The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment

P. Spanheimer, D. Ollila, P. Strassle, 2022, npj Breast Cancer.

Nodal positivity decreases with age in women with early‐stage, hormone receptor–positive breast cancer

H. Muss, D. Ollila, P. Strassle, 2019, Cancer.

ASO Author Reflections: The Impact of Virtual Interviews for Complex General Surgical Oncology Fellowship

D. Ollila, Monica M. Grova, 2021, Annals of Surgical Oncology.

Direct Comparison of In-Person Versus Virtual Interviews for Complex General Surgical Oncology Fellowship in the COVID-19 Era

Hong-Jin Kim, D. Ollila, Monica M. Grova, 2020, Annals of Surgical Oncology.

Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

L. Carey, E. Dees, K. Amos, 2011, Annals of Surgical Oncology.

Rationale for complete metastasectomy in patients with stage IV metastatic melanoma

D. Ollila, E. Hsueh, A. Gleisner, 2011, Journal of surgical oncology.

Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging

J. Yeh, A. Deal, K. Amos, 2009, Annals of Surgical Oncology.

Utility of routine PET/CT and MRI staging in patients with sentinel lymph node positive melanoma.

J. Yeh, K. Amos, D. Ollila, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience.

James X. Sun, K. Delman, D. Ollila, 2019, Journal of the American College of Surgeons.

A phase 2 trial of complete resection for stage IV melanoma

D. Ollila, 2011, Cancer.

Update on active specific immunotherapy with melanoma vaccines

D. Morton, M. Kelley, D. Ollila, 1997, Journal of surgical oncology.

Tumor doubling time: A selection factor for pulmonary resection of metastatic melanoma

D. Morton, D. Ollila, S. Stern, 1998, Journal of surgical oncology.

Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.

A. Giuliano, R. Turner, D. Ollila, 1999, The American journal of surgical pathology.

Surgical resection as the treatment of choice for melanoma metastatic to the lung.

D. Morton, D. Ollila, 1998, Chest surgery clinics of North America.

Complete metastasectomy in patients with stage IV metastatic melanoma.

D. Ollila, 2006, The Lancet. Oncology.

Surgical management of distant metastases.

A. Caudle, D. Ollila, 2006, Surgical oncology clinics of North America.

Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma.

Nooreen Dabbish, B. Leiby, A. Berger, 2017, Journal of the American College of Surgeons.

The Role of PET/CT in Melanoma Patients: A Surgeon’s Perspective

D. Ollila, E. Hsueh, Ea-Sle Chang, 2020, PET/CT and PET/MR in Melanoma and Sarcoma.

Use of Completion Lymph Node Dissection for Sentinel Lymph Node Positive Melanoma.

K. Stitzenberg, D. Ollila, Joshua N. Herb, 2020, Journal of the American College of Surgeons.

Completion Lymph Node Dissection for Select Patients with Sentinel Node-Positive Melanoma: In Reply to Bartlett and Coit.

K. Stitzenberg, D. Ollila, Joshua N. Herb, 2020, Journal of the American College of Surgeons.

Tumor doubling time and survival

D. Morton, D. Ollila, 1999, Journal of Surgical Oncology.

Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer.

M. Iacocca, L. Dressler, B. Calvo, 2002, American journal of clinical pathology.

Another Brick in the Wall: Toward a Better Understanding of Melanoma of Unknown Primary

D. Ollila, M. Meyers, 2014, Annals of Surgical Oncology.

Inherited Melanoma Risk Variants Associated with Histopathologically Amelanotic Melanoma.

S. Rosso, C. Begg, S. Madronich, 2020, The Journal of investigative dermatology.

Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers.

L. Carey, H. Neuman, D. Ollila, 2005, American journal of surgery.

Clinical significance of micrometastatic disease in the era of sentinel node.

L. Carey, D. Ollila, C. Sartor, 2001, Breast disease.

Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection

James X. Sun, Lesly A. Dossett, T. Hieken, 2022, Journal for ImmunoTherapy of Cancer.

Lymphatic mapping and sentinel lymphadenectomy for melanoma.

D. Morton, M. Kelley, D. Ollila, 1998, Seminars in surgical oncology.

Parotid Region Lymphatic Mapping and Sentinel Lymphadenectomy for Cutaneous Melanoma

D. Morton, R. Essner, D. Ollila, 1999, Annals of Surgical Oncology.

Early Recurrence in Sentinel Lymph Node Positive Stage III Melanoma Patients

A. Deal, K. Amos, D. Ollila, 2012, The American surgeon.

Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry

K. Stitzenberg, D. Ollila, Joshua N. Herb, 2021, Annals of Surgical Oncology.

An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab: A Case Report and Review of the Literature.

D. Ollila, Arya Akhavan, Nishant Bhatt, 2021, Plastic and reconstructive surgery.

Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma

S. Rosso, C. Begg, S. Madronich, 2021, JAAD international.

Functional melanoma‐risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas

S. Rosso, C. Begg, H. Anton-Culver, 2017, The British journal of dermatology.

Distance to diagnosing provider as a measure of access for patients with melanoma.

R. Millikan, M. Berwick, K. Stitzenberg, 2007, Archives of Dermatology.

Role of conservation therapy for invasive lobular carcinoma of the breast

S. Singletary, M. Ross, A. Giuliano, 2006, Annals of Surgical Oncology.

Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients

P. Spanheimer, H. Muss, D. Ollila, 2021, Breast Cancer Research and Treatment.

The Role of Intraoperative Radiation in Early-stage Breast Cancer.

G. Gupta, D. Ollila, D. Casey, 2021, Clinical breast cancer.

The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations

H. Kuerer, E. S. Hwang, K. Yao, 2018, Annals of Surgical Oncology.

Gender Bias in Surgical Oncology Fellowship Recommendation Letters: Gaining Progress.

D. Ollila, P. Strassle, Monica M. Grova, 2020, Journal of surgical education.

Laparoscopic cholecystectomy in patients admitted with acute biliary symptoms.

J. Peters, D. Ollila, J. H. Peters, 1993, American journal of surgery.

Indications for Neoadjuvant Systemic Therapy for Breast Cancer.

D. Ollila, K. Gallagher, 2019, Advances in surgery.

Sentinel lymph node biopsy controversy: Before or after neoadjuvant chemotherapy

H. Neuman, D. Ollila, 2009 .

Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

Elizabeth L. Cureton, L. Esserman, C. Yau, 2014, Annals of Surgical Oncology.

Axillary lymph node count is lower after neoadjuvant chemotherapy.

A. Meyer, L. Carey, C. Livasy, 2006, American journal of surgery.

Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?

K. Thompson, P. Beitsch, D. Ollila, 2009, Journal of the American College of Surgeons.

Phase 2 study of pre‐excision single‐dose intraoperative radiation therapy for early‐stage breast cancers

R. Kimple, D. Ollila, C. Sartor, 2013, Cancer.

The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer.

A. Giuliano, M. Brennan, D. Ollila, 1999, Advances in surgery.

International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers

James X. Sun, Lesly A. Dossett, V. Sondak, 2022, Annals of surgery.

A risk prediction model for the development of subsequent primary melanoma in a population‐based cohort

C. Begg, L. Haydu, I. Orlow, 2020, The British journal of dermatology.

Reflector Localization of Breast Lesions and Parameters Associated with Positive Surgical Margins in Women Undergoing Breast Conservation Surgery.

D. Zeng, C. Kuzmiak, S. Jordan, 2020, Journal of breast imaging.

Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma

Wei Zhao, S. Moschos, P. Googe, 2022, medRxiv.

Prophylaxis and screening options: recommendations for young women with BRCA mutations.

J. Samuel, D. Ollila, 2005, Breast disease.

Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters: A Randomized Clinical Trial.

M. Rosenbaum, Muneera R. Kapadia, D. Ollila, 2021, JAMA surgery.

The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research

K. Stitzenberg, P. Googe, D. Ollila, 2021, Annals of Surgical Oncology.

Breast Conservation Therapy Versus Mastectomy: Shared Decision-Making Strategies and Overcoming Decisional Conflicts in Your Patients

J. Margenthaler, D. Ollila, 2016, Annals of surgical oncology.

The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment

P. Spanheimer, D. Ollila, P. Strassle, 2022, NPJ breast cancer.

Impact of neoadjuvant chemotherapy plus HER2-targeting on breast conservation rates: Surgical results from CALGB 40601 (Alliance).

D. Berry, E. Winer, C. Hudis, 2013 .

Resection of Cavity Shave Margins in Stage 0–III Breast Cancer Patients Undergoing Breast Conserving Surgery

A. Chagpar, E. Levine, A. Berger, 2019, Annals of surgery.

Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer

P. Spanheimer, D. Ollila, P. Strassle, 2022, Annals of Surgical Oncology.

Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition

T. Barker, M. Troester, Wei Li, 2018, British Journal of Cancer.

MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management.

B. Calhoun, C. Kuzmiak, D. Ollila, 2020, Annals of diagnostic pathology.

Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma in Situ.

E. Levine, A. Berger, T. Tsangaris, 2020, Journal of the American College of Surgeons.

Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer

P. Spanheimer, D. Ollila, P. Strassle, 2022, npj Breast Cancer.

Phase 2 study of pre‐excision single‐dose intraoperative radiation therapy for early‐stage breast cancers

R. Kimple, D. Ollila, E. Jones, 2013, Cancer.

Breast Conservation Therapy Versus Mastectomy: Shared Decision-Making Strategies and Overcoming Decisional Conflicts in Your Patients

J. Margenthaler, D. Ollila, Facs Julie A. Margenthaler MD, 2016, Annals of Surgical Oncology.